<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lin B</submitter><funding>Natural Sciences and Engineering Research Council of Canada</funding><funding>Canada Research Chairs Program</funding><funding>Government of Ontario</funding><funding>Cystic Fibrosis Foundation</funding><funding>Cystic Fibrosis Canada</funding><funding>Genome Canada</funding><funding>Canadian Institutes of Health Research</funding><pagination>2400062</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11540985</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>64(5)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>&lt;i>Pseudomonas aeruginosa&lt;/i> is a common pathogen that contributes to progressive lung disease in cystic fibrosis (CF). Genetic factors other than CF-causing &lt;i>CFTR&lt;/i> (CF transmembrane conductance regulator) variations contribute ∼85% of the variation in chronic &lt;i>P. aeruginosa&lt;/i> infection age in CF according to twin studies, but the susceptibility loci remain unknown. Our objective is to advance understanding of the genetic basis of host susceptibility to &lt;i>P. aeruginosa&lt;/i> infection.&lt;h4>Materials and methods&lt;/h4>We conducted a genome-wide association study of chronic &lt;i>P. aeruginosa&lt;/i> infection age in 1037 Canadians with CF. We subsequently assessed the genetic correlation between chronic &lt;i>P. aeruginosa&lt;/i> infection age and lung function through polygenic risk score (PRS) analysis and inferred their causal relationship through bidirectional Mendelian randomisation analysis.&lt;h4>Results&lt;/h4>Two novel genome-wide significant loci with lead single nucleotide polymorphisms (SNPs) rs62369766 (chr5p12; p=1.98×10&lt;sup>-8&lt;/sup>) and rs927553 (chr13q12.12; p=1.91×10&lt;sup>-8&lt;/sup>) were associated with chronic &lt;i>P. aeruginosa&lt;/i> infection age. The rs62369766 locus was validated using an independent French cohort (n=501). Furthermore, the PRS constructed from CF lung function-associated SNPs was significantly associated with chronic &lt;i>P. aeruginosa&lt;/i> infection age (p=0.002). Finally, our analysis presented evidence for a causal effect of lung function on chronic &lt;i>P. aeruginosa&lt;/i> infection age (β=0.782 years, p=4.24×10&lt;sup>-4&lt;/sup>). In the reverse direction, we observed a moderate effect (β=0.002, p=0.012).&lt;h4>Conclusions&lt;/h4>We identified two novel loci that are associated with chronic &lt;i>P. aeruginosa&lt;/i> infection age in individuals with CF. Additionally, we provided evidence of common genetic contributors and a potential causal relationship between &lt;i>P. aeruginosa&lt;/i> infection susceptibility and lung function in CF. Therapeutics targeting these genetic factors may delay the onset of chronic infections, which account for significant remaining morbidity in CF.</pubmed_abstract><journal>The European respiratory journal</journal><pubmed_title>Genome-wide association study of susceptibility to &lt;i>Pseudomonas aeruginosa&lt;/i> infection in cystic fibrosis.</pubmed_title><pmcid>PMC11540985</pmcid><funding_grant_id>FRN-167282</funding_grant_id><funding_grant_id>STRUG17PO</funding_grant_id><funding_grant_id>OGI-148</funding_grant_id><funding_grant_id>FRN-310732</funding_grant_id><funding_grant_id>RGPIN-04934</funding_grant_id><funding_grant_id>RGPIN-2015-03742</funding_grant_id><funding_grant_id>2626</funding_grant_id><pubmed_authors>Mohand Oumoussa B</pubmed_authors><pubmed_authors>Strug LJ</pubmed_authors><pubmed_authors>Guillot L</pubmed_authors><pubmed_authors>Corvol H</pubmed_authors><pubmed_authors>Mesinele J</pubmed_authors><pubmed_authors>Waters V</pubmed_authors><pubmed_authors>Calmel C</pubmed_authors><pubmed_authors>Sun L</pubmed_authors><pubmed_authors>Lin B</pubmed_authors><pubmed_authors>Lin YC</pubmed_authors><pubmed_authors>Boelle PY</pubmed_authors><pubmed_authors>Lin F</pubmed_authors><pubmed_authors>Keenan K</pubmed_authors><pubmed_authors>Gong J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genome-wide association study of susceptibility to &lt;i>Pseudomonas aeruginosa&lt;/i> infection in cystic fibrosis.</name><description>&lt;h4>Background&lt;/h4>&lt;i>Pseudomonas aeruginosa&lt;/i> is a common pathogen that contributes to progressive lung disease in cystic fibrosis (CF). Genetic factors other than CF-causing &lt;i>CFTR&lt;/i> (CF transmembrane conductance regulator) variations contribute ∼85% of the variation in chronic &lt;i>P. aeruginosa&lt;/i> infection age in CF according to twin studies, but the susceptibility loci remain unknown. Our objective is to advance understanding of the genetic basis of host susceptibility to &lt;i>P. aeruginosa&lt;/i> infection.&lt;h4>Materials and methods&lt;/h4>We conducted a genome-wide association study of chronic &lt;i>P. aeruginosa&lt;/i> infection age in 1037 Canadians with CF. We subsequently assessed the genetic correlation between chronic &lt;i>P. aeruginosa&lt;/i> infection age and lung function through polygenic risk score (PRS) analysis and inferred their causal relationship through bidirectional Mendelian randomisation analysis.&lt;h4>Results&lt;/h4>Two novel genome-wide significant loci with lead single nucleotide polymorphisms (SNPs) rs62369766 (chr5p12; p=1.98×10&lt;sup>-8&lt;/sup>) and rs927553 (chr13q12.12; p=1.91×10&lt;sup>-8&lt;/sup>) were associated with chronic &lt;i>P. aeruginosa&lt;/i> infection age. The rs62369766 locus was validated using an independent French cohort (n=501). Furthermore, the PRS constructed from CF lung function-associated SNPs was significantly associated with chronic &lt;i>P. aeruginosa&lt;/i> infection age (p=0.002). Finally, our analysis presented evidence for a causal effect of lung function on chronic &lt;i>P. aeruginosa&lt;/i> infection age (β=0.782 years, p=4.24×10&lt;sup>-4&lt;/sup>). In the reverse direction, we observed a moderate effect (β=0.002, p=0.012).&lt;h4>Conclusions&lt;/h4>We identified two novel loci that are associated with chronic &lt;i>P. aeruginosa&lt;/i> infection age in individuals with CF. Additionally, we provided evidence of common genetic contributors and a potential causal relationship between &lt;i>P. aeruginosa&lt;/i> infection susceptibility and lung function in CF. Therapeutics targeting these genetic factors may delay the onset of chronic infections, which account for significant remaining morbidity in CF.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2026-06-08T06:28:23.485Z</modification><creation>2026-06-08T03:14:26.891Z</creation></dates><accession>S-EPMC11540985</accession><cross_references><pubmed>39117430</pubmed><doi>10.1183/13993003.00062-2024</doi></cross_references></HashMap>